Loading...
XJPX
2664
Market cap535mUSD
Oct 09, Last price  
3,785.00JPY
1D
0.00%
1Q
10.03%
Jan 2017
29.85%
IPO
-9.45%
Name

Cawachi Ltd

Chart & performance

D1W1MN
XJPX:2664 chart
P/E
26.42
P/S
0.30
EPS
143.28
Div yield, %
2.11%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
0.00%
Revenues
284.49b
-1.15%
207,337,000,000224,653,000,000233,959,000,000232,300,000,000235,530,000,000222,322,000,000231,657,000,000242,684,000,000258,319,000,000260,624,000,000266,423,000,000268,205,000,000264,926,000,000270,313,000,000284,492,000,000279,462,000,000281,871,000,000285,960,000,000287,816,000,000284,492,000,000
Net income
3.20b
-34.48%
5,483,000,0005,887,000,0002,502,000,0003,691,000,0003,800,000,0004,417,000,0002,066,000,0002,015,000,000-4,673,000,0001,975,000,0003,510,000,0003,869,000,0002,016,000,0003,822,000,0007,109,000,0004,830,000,0004,177,000,0004,713,000,0004,884,000,0003,200,000,000
CFO
8.87b
+18.50%
10,599,000,0009,984,000,00011,030,000,0007,301,000,0009,057,000,0007,903,000,0008,577,000,00010,164,000,0005,513,000,00011,089,000,0008,835,000,0008,600,000,0006,684,000,00012,159,000,00015,267,000,0006,868,000,0009,817,000,0006,402,000,0007,481,000,0008,865,000,000
Dividend
Mar 12, 202750 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Cawachi Limited manages drugstores in Japan. It is involved in retail and insurance dispensing of medicines, medical-related products, health foods, childcare products, cosmetics, daily necessities, general foods, confectionery. The company was founded in 1960 and is headquartered in Oyama, Japan.

Key people

Hiroshi Asuke
Executive Officer, Director of Administration · since 2021
Katsuyuki Ohkubo
Director of Store Development, President of Subsidiary, Director · since 2022
Shinji Kawachi
President, Representative Director · since 2018
Miho Eto
Independent Director · since 2022
Rinji Watanabe
Independent Director · since 2016
URL
https://www.cawachi.co.jp/
IPO date
Sep 01, 2000
Employees
2,770
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT